Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Male dogs more likely to develop contagious oro-nasal cancer
"We think it's important to consider CTVT as a possible diagnosis for oro-nasal tumours in dogs" - Dr Andrea Strakova.
Researchers believe this may be due to behavioural differences.

Male dogs are four to five times more likely to develop a contagious cancer on their nose and mouth than female dogs, a study from the University of Cambridge has found.

Canine Transmissible Venereal Tumour (CTVT) is spread when dogs come into contact. An infectious cancer, the living cancer cells are able to transplant from one dog into another.

CTVT affects the genitalia of dogs most commonly, and is often transmitted during mating, however, the cancer can also affect a dog's nose, mouth and skin. The oro-nasal form of CTVT is transmitted through the sniffing or licking dogs' genitalia.

Dr Andrea Strakova, first author of the paper, explained: “We found that a very significant proportion of the nose or mouth tumours of canine transmissible cancer were in male dogs.

“We think this is because male dogs may have a preference for sniffing or licking the female genitalia, compared to vice versa. 

“The female genital tumours may also be more accessible for sniffing and licking, compared to the male genital tumours.”

In the study, researchers reviewed a database of almost 2,000 CTVT cases worldwide, finding that only 32 cases affected the nose and mouth. Of these cases, 27 were male dogs.

Dr Strakova discussed the importance of veterinary surgeons being aware of oro-nasal CTVT:
“Although canine transmissible cancer can be diagnosed and treated fairly easily, veterinarians in the UK may not be familiar with the signs of the disease because it is very rare here.

“We think it’s important to consider CTVT as a possible diagnosis for oro-nasal tumours in dogs. Treatment is very effective, using single agent Vincristine chemotherapy, and the vast majority of dogs recover.”

Signs of the oro-nasal form of CTVT include sneezing, snoring, difficulty breathing, nasal deformation or bloody or other discharge from the nose or mouth.

Published in Veterinary Record, 'Sex disparity in oronasal presentations of canine transmissible venereal tumour' is available to read here

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com